: Vertex’s stock heads for all-time high as non-opioid painkiller shows promise

Vertex Pharmaceuticals’ stock was on track for an all-time high Wednesday after the company released new data on its experimental non-opioid pain medicine.

Previous post SpaceX valuation climbs to $180 billion, higher than Boeing, Verizon market caps
Next post : Etsy to cut 11% of staff as CEO says company is on ‘unsustainable trajectory’